154 related articles for article (PubMed ID: 18175264)
1. Ethnic variation in drug response: implications for the development and regulation of drugs.
Johnson DE; Park BK; Smith DA
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):29-31. PubMed ID: 18175264
[No Abstract] [Full Text] [Related]
2. The clinical pharmacologist in drug regulation: the US perspective.
Temple RJ
Br J Clin Pharmacol; 1996 Jul; 42(1):73-9. PubMed ID: 8807147
[TBL] [Abstract][Full Text] [Related]
3. The influence of host factors on drug response. I. Ethnic background.
Vesell ES
Ration Drug Ther; 1979 Aug; 13(8):1-7. PubMed ID: 531214
[No Abstract] [Full Text] [Related]
4. Ethnic differences in reactions to drugs and xenobiotics. Outlook of a pharmacologist.
Kalow W
Prog Clin Biol Res; 1986; 214():3-7. PubMed ID: 3725766
[No Abstract] [Full Text] [Related]
5. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
6. Intraspecies differences in frequency of genes directly affecting drug disposition: the individual factor in drug response.
Vesell ES
Pharmacol Rev; 1978 Dec; 30(4):555-63. PubMed ID: 757292
[No Abstract] [Full Text] [Related]
7. [Experience with phase I of clinical pharmacology in the registration of drugs].
von Eickstedt KW
Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1677-8. PubMed ID: 4801617
[No Abstract] [Full Text] [Related]
8. Informed consent--a new approach to drug regulation?
Nutt DJ
J Psychopharmacol; 2006 Jan; 20(1):3-4. PubMed ID: 16354734
[No Abstract] [Full Text] [Related]
9. 'Designer Drug' Enforcement Act seeks to attack problem at source.
Hagerty C
Am Pharm; 1985 Oct; NS25(10):10-1. PubMed ID: 4061277
[No Abstract] [Full Text] [Related]
10. Contempo '81. Trends in regulation and development of new drugs.
Ballin JC
JAMA; 1981 Jun; 245(21):2161-3. PubMed ID: 7230409
[No Abstract] [Full Text] [Related]
11. Ethnic factors: implications for drug therapy and global drug development. AGAH annual meeting, Heidelberg, 7-9 February 1999. Abstracts.
Int J Clin Pharmacol Ther; 1999 Apr; 37(4):193-206. PubMed ID: 10383220
[No Abstract] [Full Text] [Related]
12. Drugs, their targets and the nature and number of drug targets.
Imming P; Sinning C; Meyer A
Nat Rev Drug Discov; 2006 Oct; 5(10):821-34. PubMed ID: 17016423
[TBL] [Abstract][Full Text] [Related]
13. Studies target ethnic and racial differences in drug metabolism.
Richardson M
Tex Med; 1993 Oct; 89(10):46-8. PubMed ID: 8248876
[No Abstract] [Full Text] [Related]
14. [Influence of current drug legislation on the development of new drugs (author's transl)].
Bethge H
Offentl Gesundheitswes; 1980 Nov; 42(11):853-8. PubMed ID: 6450917
[No Abstract] [Full Text] [Related]
15. China takes first steps toward healthcare and drug reforms.
Hughes V
Nat Med; 2008 Nov; 14(11):1132. PubMed ID: 18989266
[No Abstract] [Full Text] [Related]
16. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
Lalonde RL; Wagner JA
Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
[TBL] [Abstract][Full Text] [Related]
17. [What rules apply here and who is responsible? How drugs are distinguished from other health care products?].
Stephan K
Pharm Unserer Zeit; 2011 Jul; 40(4):300-4. PubMed ID: 21698627
[No Abstract] [Full Text] [Related]
18. Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.
Kumar S; Kassahun K; Tschirret-Guth RA; Mitra K; Baillie TA
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):43-52. PubMed ID: 18175266
[TBL] [Abstract][Full Text] [Related]
19. Designing transient binding drugs: a new concept for drug discovery.
Ohlson S
Drug Discov Today; 2008 May; 13(9-10):433-9. PubMed ID: 18468561
[TBL] [Abstract][Full Text] [Related]
20. [Drugs: molecular pharmacology, sites of action and drug receptors].
Astier A
Soins; 1984 Oct; (439):13-25. PubMed ID: 6569695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
